Batten disease - Wikipedia Batten disease is a terminal illness; the FDA has approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease Brineura is the first FDA-approved treatment to slow loss of walking ability (ambulation) in symptomatic pediatric patients three years of age and older with late infantile neuronal ceroid lipofuscinosis
Batten Disease: Symptoms, Life Expectancy, and Age of Onset Batten Disease is a fatal, inherited disorder of the nervous system that begins in childhood It is named after the British pediatrician who first described it in 1903 Also known as Spielmeyer-Vogt-Sjogren-Batten Disease, it is the most common form of a group of disorders called neuronal ceroid lipofuscinoses (or NCLs)
Batten Disease (Juvenile Neuronal Ceroid Lipofuscinosis) Neuronal ceroid lipofuscinoses (NCLs), or Batten disease, are a group of devastating and lethal neurodegenerative lysosomal storage diseases that typically affect children The disease is known to have 14 forms, each resulting from mutations in a distinct gene
What is Batten? - Beyond Batten Disease Foundation Batten disease is one of a group of disorders known as neuronal ceroid lipofuscinoses (NCLs) Over 400 different errors (mutations) in 13 segments of DNA (genes) have been attributed to various forms of Batten, which differ from one another primarily by when symptoms first appear